Clinical trial
The Effects of Therapy With Teriparatide on Vascular Compliance and…
NCT00347737 · Leland Graves III, MD, Other · Withdrawn
Key facts
| NCT number | NCT00347737 |
|---|---|
| Title | The Effects of Therapy With Teriparatide on Vascular Compliance and Osteoprotegerin/RANKL |
| Official title | The Effects of Therapy With Teriparatide (Recombinant Parathyroid Hormone (1-34) on Vascular Compliance and Osteoprotegerin/RANKL |
| Lead sponsor | Leland Graves III, MD, Other |
| Collaborators | University of Kansas |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | teriparatide |
| Enrollment | 0 |
| Start date | Jun 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Jul 4, 2006 |
| Last update posted | Jan 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: